Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders-Reference-Cited by-同舟云学术

Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders

Published:2018-02 Issue: Volume:122 Page:202-207
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Tolba Mai F.,Omar Hany A.

Funder

Fulbright scholar research

L'Oreal UNESCO for Women in Science Levant and Egypt award

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference67 articles.

1. Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC);Adams;J. Clin. Oncol.,2016

2. Reprogramming the immunological microenvironment through radiation and targeting Axl;Aguilera;Nat. Commun.,2016

3. Novel opportunities to use radiation therapy with immune checkpoint inhibitors for melanoma management;Ahmed;Surg. Oncol. Clin. N. Am.,2017

4. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes;Alfaro;Br. J. Cancer,2009

5. The evolution of triple-Negative Breast cancer: from biology to novel therapeutics;Anders;Am. Soc. Clin. Oncol. Educ. Book,2016

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy;ACS Nano;2023-01-04

2. Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer;Cancers;2022-12-23

3. Lipid Metabolism Heterogeneity and Crosstalk with Mitochondria Functions Drive Breast Cancer Progression and Drug Resistance;Cancers;2022-12-19

4. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers;Journal for ImmunoTherapy of Cancer;2022-09

5. Recent Progress on Therapeutic Vaccines for Breast Cancer;Frontiers in Oncology;2022-06-06